Mutual of America Capital Management LLC Reduces Stake in Chemed Co. (NYSE:CHE)

Mutual of America Capital Management LLC reduced its stake in shares of Chemed Co. (NYSE:CHEFree Report) by 9.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,700 shares of the company’s stock after selling 1,148 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Chemed were worth $5,561,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Asset Management One Co. Ltd. grew its position in Chemed by 20.0% during the 2nd quarter. Asset Management One Co. Ltd. now owns 120 shares of the company’s stock worth $65,000 after acquiring an additional 20 shares during the last quarter. Fiduciary Planning LLC grew its holdings in Chemed by 1.0% in the 2nd quarter. Fiduciary Planning LLC now owns 2,211 shares of the company’s stock worth $1,198,000 after acquiring an additional 21 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Chemed by 0.5% in the third quarter. Fifth Third Bancorp now owns 3,914 shares of the company’s stock valued at $2,034,000 after acquiring an additional 21 shares during the period. Deutsche Bank AG boosted its holdings in shares of Chemed by 0.5% during the first quarter. Deutsche Bank AG now owns 4,893 shares of the company’s stock worth $2,631,000 after purchasing an additional 22 shares during the period. Finally, IHT Wealth Management LLC increased its holdings in Chemed by 3.8% during the 2nd quarter. IHT Wealth Management LLC now owns 624 shares of the company’s stock valued at $338,000 after purchasing an additional 23 shares during the period. 94.25% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Royal Bank of Canada boosted their target price on Chemed from $576.00 to $604.00 and gave the company an “outperform” rating in a research note on Monday, October 30th. Oppenheimer boosted their price objective on shares of Chemed from $590.00 to $625.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th.

Get Our Latest Research Report on CHE

Insider Activity at Chemed

In other news, EVP Spencer S. Lee sold 1,000 shares of the company’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $579.73, for a total value of $579,730.00. Following the sale, the executive vice president now directly owns 22,568 shares of the company’s stock, valued at approximately $13,083,346.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction on Monday, December 11th. The stock was sold at an average price of $572.77, for a total transaction of $859,155.00. Following the completion of the transaction, the chief executive officer now directly owns 111,468 shares in the company, valued at $63,845,526.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Spencer S. Lee sold 1,000 shares of the stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $579.73, for a total transaction of $579,730.00. Following the sale, the executive vice president now directly owns 22,568 shares in the company, valued at $13,083,346.64. The disclosure for this sale can be found here. 3.80% of the stock is currently owned by corporate insiders.

Chemed Stock Performance

CHE stock opened at $589.00 on Monday. Chemed Co. has a fifty-two week low of $490.87 and a fifty-two week high of $610.35. The company has a market capitalization of $8.87 billion, a price-to-earnings ratio of 36.47, a price-to-earnings-growth ratio of 2.88 and a beta of 0.43. The business’s 50 day moving average price is $585.79 and its two-hundred day moving average price is $549.96.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.